LIFERIVER(SH:688317) Xin Lang Cai Jing·2025-08-26 05:36Core Viewpoint - Zhijiang Biotechnology experienced a 5% decline in stock price, currently trading at 27.53 CNY per share, with a market capitalization of 5.29 billion CNY [1] Company Overview - Shanghai Zhijiang Biotechnology Co., Ltd. was established on April 18, 2005, and went public on January 18, 2021. The company specializes in the research, production, and sales of molecular diagnostic reagents and equipment [1] - The revenue composition of the company includes: 82.71% from nucleic acid testing kits, 10.54% from other products, 5.00% from molecular diagnostic instruments, and 1.75% from other sources [1] Shareholder Information - Dazhong Fund's Dazhong Jingheng Mixed A (090019) is among the top ten circulating shareholders of Zhijiang Biotechnology, holding 909,200 shares, which represents 0.47% of the circulating shares. The fund has incurred an estimated floating loss of approximately 1.32 million CNY today [2] - Dazhong Jingheng Mixed A was established on June 15, 2012, with a current scale of 397 million CNY. Year-to-date returns are 37.41%, ranking 1284 out of 8194 in its category, while the one-year return is 103.51%, ranking 262 out of 7962. Since inception, the fund has achieved a return of 361.38% [2] Fund Management - The fund manager of Dazhong Jingheng Mixed A is Su Bingyi, who has a tenure of 13 years and 203 days. The total asset size of the fund is 1.24 billion CNY, with the best return during his tenure being 240.01% and the worst being -71.74% [3] Fund Holdings - Dazhong Jingheng Mixed A holds 909,200 shares of Zhijiang Biotechnology, unchanged from the previous period, accounting for 1.97% of the fund's net value, making it the sixth-largest holding. The estimated floating loss today is approximately 1.32 million CNY [4]